Demystifying Cancer Genomics: A Practical Workshop for Clinicians
THURSDAY, 25 SEPTEMBER 2025
2:00 PM-5:30 PM @ AMARI Hotel Johor Bahru
| TIME | TOPICS |
| 1400 - 1730 | Demystifying Cancer Genomics: A Practical Workshop for Clinicians |
| 1400 - 1410 | Welcome & Workshop Overview Moderator: Adj Prof Dr Voon Pei Jye |
| 1410 - 1435 | Essentials of NGS in Oncology - Fundamentals & Clinical Relevance Dr Francis Tieng Yew Fu |
| 1435 - 1500 | NGS Techniques Mr Sayyidi Hamzi |
| 1500 - 1515 | Break |
| 1515 - 1540 | Interpreting NGS Reports & Clinical Decision-Making Dr Venkata Pradeep Babu Koyyala |
| 1540 - 1605 | Immunogenomics & Precision Immunotherapy in Oncology Dr Roziana Ariffin |
| 1605 - 1630 | Challenges & Pitfalls in Oncology NGS Prof Dr Tony Lim Kiat Hon |
| 1630 - 1730 | Molecular Tumour Board Panel Discussion : Real-World Insights Case-Based Learning: Live Interpretation of NGS Report |
FRIDAY, 26 September 2025
MOS Members Lounge
MOS Members Lounge will be opened from 0900-1700
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
| 0800 onwards | REGISTRATION |
||
| 0900 - 1030 | Plenary Session 1: Democratizing Cancer Care: Closing the Global Oncology Gap Chairpersons: Dr Vaishnavi Jeyasingam & Dr Flora Chong Li Tze |
||
| 0900 - 0920 | Addressing Inequities in Access to New Drugs and Clinical Trials by NPRA Dr Zaril Harza Zakaria |
||
| 0920 - 0940 | Democratising Cancer Care: Closing the Global Oncology Gap, Malaysia Perspective Dr Ros Suzanna Ahmad Bustamam |
||
| 0940 - 1000 | Democratising Cancer Care: Closing the Global Oncology Gap, Learning from the Experience Prof Dr C.S. Pramesh |
||
| 1000 - 1030 | Forum Discussion | ||
| 1030 - 1050 | Break | ||
| 1050 - 1130 | OPENING CEREMONY | ||
| 1130 - 1230 | Keynote Address: Thriving Beyond Cancer; Empowering Survivor for a Healthier Future Chairpersons: Dr Fong Chin Heng & Dr Azura Deniel |
||
| 1130 - 1150 | Comprehensive Survivorship Care Plans Dr Mothi Babu Ramalingam |
||
| 1150 - 1210 | Financial Toxicity of Cancer in Asian Setting Prof Dr Nirmala Bhoo Pathy |
||
| 1210 - 1230 | Workplace Reintegration Dr Nik Khairol Reza Md Yazin |
||
| 1230 - 1300 | Break | ||
| 1300-1400 |
Lunch Symposium by AstraZeneca Perioperative Treatment Strategy for GC / GEJC: Incorporating Immunotherapy Chairperson: |
Lunch Symposium by Pfizer ALK+ NSCLC Revolution: How Far Have We Come and Where Are We Going? Chairperson: |
Lunch Symposium by BMS Navigating Complexity to Improve Outcomes in HCC Chairperson: |
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
Onco Exchange Foyer, Level 3 | Onco Exchange Foyer, Level 3 |
| 1400 - 1530 | Lower GI Chairpersons: Dr Eznal Izwadi Mohd Mahidin & Dr Ooi Po Lin |
Early Lung Chairpersons: Dr Norhidayu Salimin & Dr Tan Ai Lian |
Dialog Session: Cancer Support Group Chairperson: Dato' Dr Mohamed Ibrahim A. Wahid & Dr Natasha Mohd Hashim |
Onco Exchange 1.1: Breast Cancer 1415 - 1515 Chairperson: Dr Peter Low Qin Jian Speaker: Dr Dejan Juric |
Onco Exchange 1.2: Gynae 1415 - 1515 Chairperson: Dr Rangasamy Ramachandran Panel: Clin Asst Prof Chan Junjie Jack, Asst Prof Dr Raviteja Miriyala |
| 1400 - 1410 | Evolving Surgical Approaches in Rectal Cancer Dr Muhammad Ash Shafhawi Adznan |
Surgical Consesus Key Statement Recommendations for Early Stage Receptable NSCLC Prof Dr Anand Sachithanandan |
iCARE Cancer Support Association Introduction Ms Lyn Lin Tyng |
||
| 1410 - 1420 | The Breast Cancer Support Group Johor Bahru Introduction Datin Ang Chin Fan |
||||
| 1420 - 1430 | Optimal Approach to Oligometastatic Colorectal Ca Dr Nur Fadhlina Abdul Satar |
Advancements in Early Detection Techniques Dr Aida Abdul Aziz |
Palliative Care Association of Johor Bahru (PCAJB) Introduction Ms Premala Ponnusamy |
||
| 1430 - 1440 | Yayasan Kanser Tunku Laksamana Johor Introduction Dr Mohd Roslan Haron |
||||
| 1440 - 1450 | mCRC: Year in Review Dr Ramya Venkateswaran |
Challenges in Diagnosing Early-Stage Lung Cancer Dr Ng Khai Lip |
CAN-CARE Health Systems Sdn Bhd Introduction Ms Maria Khong |
||
| 1450 - 1500 | MDT Discussion Between Colorectal Surgeon and Oncologists | The Expanding Role of Immunotherapy and TKI in Early Lung Cancer Dr Daniel Chan Boon Yeow |
PERKESO Introduction Mr Aizuddin Mohamed Mansor |
||
| 1500 - 1520 | Dialog Session | ||||
| 1520 - 1530 | Q&A | Q&A | |||
| 1530 - 1615 |
TEA SYMPOSIUM BY Beigene Checkpoint Inhibitors in Nasopharyngeal Carcinoma (NPC): Evolving Treatment Landscape in NPC Chairperson: |
TEA SYMPOSIUM BY Johnson
& Johnson Redefining the Treatment Landscape for Advanced EGFRm NSCLC Chairperson: Dr Daniel Chan Boon Yeow, Senior Consultant, Specialist in Medical Oncology |
TEA SYMPOSIUM |
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
| 1615 - 1635 | Break | ||
| 1635 - 1725 | Upper GI Chairpersons: Dr Jenson Sow Wen Jen & Dr Tun Mohd Azlan Mohamed Nor |
Advanced Lung Chairpersons: Dr Lim Chun Sen & Adj Prof Dr Voon Pei Jye |
Wellness and Nutrition in Cancer Care Chairpersons: Dr Ahmad Naufal Md Alwi & Dr Nurul Iman Fathi |
| 1635 - 1655 | Challenges in Managing Potentially Resectable Gastric Cancers Dr Hans Alexander Mahendran |
Systemic Treatment for Brain Metastases in Lung Cancer Dr Tho Lye Mun |
Nutrition: Can I Eat That? Nutrition for Cancer Patients Dr Nur Hana Hamzaid |
| 1655 - 1715 | New Frontier of Locally Advanced Gastic/ GEJ Cancer Assoc Prof Dr Wan Zamaniah Wan Ishak @ Wan Mohammad |
Role of Surgery and Symptom Management in Metastatic Lung Cancer Dr Diong Nguk Chai |
Wellness: Cancer and Physical Activity: How Much is Enough? Dr Ibrahim Ahmad Fuad |
| 1715 - 1725 | Q&A | Q&A | Q&A |
| 1900 - 2200 | CONGRESS DINNER (R.S.V.P ONLY) | ||
SATURDAY, 27 September 2025
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
Onco Exchange Foyer, Level 3 | Onco Exchange Foyer, Level 3 |
| 0800 onwards | REGISTRATION |
|
|
||
| 0830 - 0900 | Plenary Session 2 Chairpersons: Dr Chong Kwang Jeat & Dr Tang Shir Ley AI in Oncology: Revolution or Illusion? Dr Nesaretnam Barr Kumarakulasinghe |
||||
| 0900 - 0945 |
Tea Symposium by Servier Chairperson: |
Tea Symposium by Zuellig Pharma The Importance of Patient Selection in HR+HER2- High Risk EBC to Optimize Treatment and Reduce Recurrence with Abemaciclib |
Tea Symposium by Astellas Pharma Malaysia Advancement in Metastatic Urothelial Cancer Care in Asia: The Role of Enfortumab vedotin and Pembrolizumab |
||
| 0945 - 1005 | Break | ||||
| 1005 - 1110 | Hepatobiliary Chairpersons: Dr Khairiyah Sidek & Dr Katherine Teh Hooi Lay |
Early Breast Cancer Chairpersons: Dr Nur Fadhlina Abdul Satar & Dr Angel Kwan Khor Nee |
RTT Chairpersons: Mr Mohd Farihan Jaffar & Dr Noor Shatirah Mohd Fandi Voon |
Onco Exchange 2.1: Prostate 1005 - 1105 Chairperson: Dr Ahmad Radzi Ahmad Badruddin Speakers: Prof Dr Ravindran Kanesvaran, Assoc Prof Dr Melvin Chua, Assoc Prof Dr Marniza Saad |
Onco Exchange 2.2: Lung 1005-1105 Chairperson: Adj Prof Dr Voon Pei Jye Speaker: Prof Dr Samreen Ahmed |
| 1005 - 1025 | Downstaging Hepatocellular Carcinoma: Getting the Right Systemic Treatment Before Local Therapy Clin Assoc Prof Dr David Tai Wai Meng |
De-escalation: Who Can Safely Receive Less Treatment? Dr Kiley Loh Wei-Jen |
Abdominal Compression in managing respiratory motion during liver SBRT Mr Mohd Khairul Mohd Zambri |
||
| 1025 - 1045 | Cutting-edge Development in Local Regional Therapy with Hepatocellular Carcinoma Prof Dr Pierce Chow Kah-Hoe |
Escalation: Who Truly Needs Enhanced Treatment? Dr Vaishnavi Jeyasingam |
Harnessing Technology and Human Touch: Future Directions for Radiation Therapists Ms Nurul Fazreen Mohd Nadzri |
||
| 1045 - 1105 | Emerging Role of Biomarkers for Diagnosis and Therapeutic Options in Biliary Tract Cancer Dr Wong Yoke Fui |
Challenges & Decision- Making in Post- Neoadjuvant Surgery Prof Dr See Mee Hong |
Enhancing Patient Accuracy with Surface-guided Radiotherapy techniques Ms Farah Afrina Ismail |
||
| 1105 - 1110 | Q&A | Q&A | Q&A |
|
|
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
Onco Exchange Foyer, Level 3 |
| 1110 - 1225 | Gyneoncology Chairpersons: Dr Prathepamalar Yehgambaram & Dr Rangasamy Ramachandran |
Advanced Breast Cancer Chairpersons: Dr Natasha Mohd Hashim & Dr Cheo Seng Wee |
Physics Chairpersons: Dr Janatul Madinah Wahabi & Dr Jong Wei Loong |
Onco Exchange 3: RTT Chairpersons: Speakers: |
| 1110 - 1130 | How Do I Treat Advanced Endometrial Cancer in 2026 Clin Asst Prof Jack Chan Junjie | The Role of Antibody-Drug Conjugates (ADCs) in Metastatic HER2+ & HER2-Low Breast Cancer : Expanding the Role of ADCs – Where Do They Fit in Treatment Sequencing? Dr Shaheenah Dawood |
AI Fundamentals for Medical Physicist Dr Tan Li Kuo |
|
| 1130 - 1150 | HiPEC in Ovarian Cancer: Hope in the Heat Prof Dr Myong Cheol Lim |
Endocrine Resistance in HR+/HER2- Advanced Breast Cancer: When to Switch or Intensify? Dr Dejan Juric |
Treatment Plan Evaluation using Plan Complexity Metric Ms Nur Diyana Afrina Mohd Hizam |
|
| 1150 - 1210 | Embrace vs Interlace :The Ultimate Showdown in Cervical Cancer Treatment Asst Prof Dr Raviteja Miriyala |
MDT: Managing Oligometastatic Disease in Breast Cancer Dr Mastura Md Yusof Panel:Dr Kiley Loh, Prof DrSee Mee Hong, Dr Vaishnavi Jeyasingam |
Advancing Precision: VMAT Techniques for Craniospinal Irradiation Ms Noor Naslinda Noor Rizan |
|
| 1210 - 1225 | Q&A | Q&A | ||
| 1225 - 1325 |
Lunch Symposium by MSD Uncovering New Approaches in the Management of Primary Advanced/Recurrent Endometrial Cancer |
Lunch Symposium by Novartis Breaking Barriers In Breast Cancer Care: The Future of HR+ HER2- Treatment |
Redefining Lung Cancer Care with Tecentriq SC: World’s First Subcutaneous Immunotherapy |
|
| 1325 - 1345 | Break | |||
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
Onco Exchange Foyer, Level 3 | Onco Exchange Foyer, Level 3 |
| 1345 - 1450 | Kidney Debate: “To Cut or Not to Cut? The Fate of Cytoreductive Surgery in the Age of Immunotherapy!” Chairpersons: Dr Lim Chun Sen & Dr Daniel Gan Eng Hwee |
Biomarkers/ Genetics Chairpersons: Dr Ahmad Radzi Ahmad Badruddin & Mr Sayyidi Hamzi |
Nursing Chairperson: Ms Nor Zaipah Sulong |
||
| 1345 - 1350 | Case Presentation Dr Tan Kee Nam |
Unlocking the Code to Personalised Cancer Care Ms Jahnavi Kesavamatham |
Oncology Nurse Navigator Ms Maheswari Jaganathan |
||
| 1350 - 1405 | Proposition Dr Allen Sim Soon Phang |
||||
| 1405 - 1410 | IInterpretation and Counselling for Genetic Testing - From the Common to the Rare Genes Ms Yoon Sook Yee |
Cultural Sensitivity in Oncology Care – Addressing Diverse Patient Needs with Empathy Mdm Ho Sweet Lee |
|||
| 1410 - 1425 | Opposition Dr Peter Low Qin Jian |
||||
| 1425 - 1430 | |||||
| 1445 - 1450 | Discussion | ||||
| Q&A | Q&A | ||||
| 1450 - 1535 |
Tea Symposium by IPSEN Redefining First-Line Therapy in RCC : Long Term Outcomes of TKI + IO |
Tea Symposium by AstraZeneca LAURA: Leading Advances and Unveiling Real Answers for UR Stage III EGFRm NSCLC |
Tea Symposium by Rxillient Health Malaysia Current IO Treatment Updates in Nasopharyngeal Carcinoma and Future Directions |
||
| 1535 - 1555 | Break | Best Poster Presentation Award Judging Session 1515-1615 |
|||
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
| 1555 - 1700 | Prostate & Bladder Chairpersons: Dr Chong Chan Teng & Dr Yap Beng Khiong |
Immunotherapy/ADC Chairpersons: Dr Ahmad Radzi Ahmad Badruddin & Dr Ang Choon Seong |
Nursing Chairperson: Ms Nor Zaipah Sulong |
| 1555 - 1615 | Metastasis-Directed Therapy in Prostate Cancer: Game-Changer or Premature Gamble? Assoc Prof Dr Melvin Chua |
Minimal Residual Disease Prof Dr Ho Gwo Fuang |
Management of Stoma Care Mdm Mariam Mohd Nasir |
| 1615 - 1635 | Navigating New Frontiers: Recent Developments in Prostate Cancer Management Assoc Prof Dr Ravindran Kanesvaran |
Science of ADC - Present and Future Challenges Dr David Lee Dai Wee |
Understanding and Coping with Chemotherapy Side Effects Ms Ong Yoke Ching |
| 1635 - 1655 | Smart Bombs Against Bladder Cancer: The Rise of Antibody-Drug Conjugates Dr Yugarajah Asokumaran |
CAR T-cell in Solid Tumour Dato' Dr Chang Kian Meng |
Recognising Early Sign of Immune- related Adverse Events and Toxicities from Targeted Therapies Mdm Latipah Abdul Wahab |
| 1655 - 1700 | Q&A | Q&A | Q&A |
| 1700 - 1900 | ANNUAL GENERAL MEETING (MOS MEMBERS ONLY) | ||
SUNDAY, 28 September 2025
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
Onco Exchange Foyer, Level 3 |
| 0800 onwards | REGISTRATION |
|||
| 0830 - 0900 | Plenary Session 3 Chairpersons: Dr Daniel Wong Wai Yan & Dr Izzati Wan Maharuddin Beyond Cure: Addressing the Psychosocial Fallout in AYA Cancer Survivors Dr Eileen Poon Yi Ling |
|||
| 0900 - 0945 |
Tea Symposium by Mega Bio-Life Real-Word Retrospective Non Interventional Study with APRITANT IV Containing Regimen for Prophylaxis of CINV in Malaysian Subjects Receiving Moderately and Highly Emetogenic Chemotherapy Chairperson: |
Tea Symposium by Medcin Phama Spinery: Redefinitng Vertebral Metastases Management - One Ablation at a Time Chairperson: |
Tea Symposium |
|
| 0945 - 1005 | Break | |||
| 1005 - 1135 | CNS Chairpersons: Dr Anbarasan Anbazagan & Dr Vickee Rajeswaran |
Turning the Tide on Liver Metastases - MDT Approach Chairpersons: Dr Audi Adawiah Sulaiman Shah & Dr Hayani Abdul Wahid |
Onco Rehab & Psychology Chairpersons: Dr Chiam Poh Jeann & Dr Yeo Geok Gee |
Onco Exchange 5.1: |
| 1005 - 1025 | Paediatric Medulloblastomas - A Crash Course for Clinical Oncologists Dr Rasheila Ganapathi |
Liver Metastases: Navigating the Present Landscape Dr Malwinder Singh Sandhu |
Psychosocial Interventions to Support Caregivers of Patients with Cancer Dr Agnes Chong Shu Sze |
|
| 1025 - 1045 | Treating Medulloblastomas in a Limited Resource Setting - Tips and Tricks Dr Flora Chong Li Tze |
Lighting up Liver Metastases: Role of Nuclear Medicine Dr Anthony Louis Anak Kindu |
Integrating Supportive Care Training for Future Professionals: the Right and Wrong Way of Communicating Dr Nor Aniza Azmi |
|
| 1045 - 1105 | Addressing Late Toxicities in Paediatric CNS RT Dr Nisha Mohd Shariff |
Guided by Imaging, Driven by Precision: IR in Liver Metastases Dr Melisa Lim Seer Yee |
Head and Neck Cancer Rehabilitation Dr Sharon Anne Khor |
|
| 1105 - 1135 | Q&A | MDT (Liver Metastases): Cases Involving Oncologist, IR, Radiation Oncologist, Nuclear Physician, Surgeon | Q&A | |
| TIME | BALLROOM 1 Room 301 |
BALLROOM 2 Room 302 |
BALLROOM 3 Room 303 |
| 1135 - 1250 | Advanced Radiotherapy Chairpersons: Dr Najihah Abu Bakar & Dr Sandya Subramaniam |
Oral Presentation | Palliative & Hospice Care Chairpersons: Dr Aaron Hiew & Dr Kumutha Chalaya |
| 1135 - 1155 | Proton Therapy in Paediatric CNS Tumours Assoc Prof Dr Kanjana Shotelersuk |
Advanced Care Planning (ACP) - From Theory to Practice :
the Sabah Experience Dr Ng Wan Jun |
|
| 1155 - 1215 | Application of Proton Therapy for Head and Neck Cancers : Sharing of Evidence and Experience Dr Sapna Nangia |
Recognising the Right Time: Timely Palliative Care & Prognostification in Oncology Dr Look Mei Ling |
|
| 1215 - 1235 | Tongue HyBIRT : Brachytherapy Followed by IMRT in the Treatment of Tongue Cancer Assoc Prof Dr Gokula Kumar Appalanaido |
Community Palliative Care & Domiciliary Service - Hospis Perspective Ms Premala Ponnusamy |
|
| 1235 - 1250 | Q&A | Q&A | |
| 1250 - 1320 | CLOSING CEREMONY | ||
Social Events
DISCLAIMER: Whilst every attempt would be made to ensure all aspects of the conference mentioned in the Programme will take place as scheduled, the Organising Committee assumes no responsibility should it fail to materialize due to any unforeseen circumstances.